US-based medical device company CHF Solutions has signed a distribution agreement with SysteMedic to make its ultrafiltration therapy available for patients in Israel and Palestine.

It is the company’s second distribution partnership in the Middle East region and it expands the commercial availability of Aquadex SmartFlow ultrafiltration therapy to 16 countries outside the US.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Aquadex SmartFlow system is a fluid management platform. The system uses ultrafiltration to stabilise patients, experiencing fluid overload, and enable providers to manage their patients’ fluid balance with precision, control and ease.

Approximately 2% of the Israeli population is estimated to suffer from heart failure, while 90% of hospitalisations among heart failure patients are due to the signs and symptoms of fluid overload.

CHF Solutions chairman and CEO John Erb said: “CHF Solutions is committed to making ultrafiltration therapy available for patients throughout the world. Our partnership with SysteMedic demonstrates continued execution on that strategy.

“Subject to regulatory approval, we look forward to working with SysteMedic to make the simple, flexible and smart Aquadex SmartFlow system available to patients in Israel and Palestine, suffering from fluid overload due to heart failure, cardiovascular surgery and other critical care conditions.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Commenting on the agreement, SysteMedic general manager Arik Yanco said: “We are very excited to work with CHF Solutions to introduce their ultrafiltration technology to Israel and Palestine.”

“We believe the Aquadex therapy will make a difference in the quality of lives of patients and look forward to a successful partnership.”

Israel-based SysteMedic imports and markets medical products and technologies to hospitals, health services, private clinics, home care, government and military customers in Israel and Palestine.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact